Last: | $20.58 |
---|---|
Change Percent: | -0.54% |
Open: | $20.61 |
Close: | $20.58 |
High: | $20.77 |
Low: | $20.43 |
Volume: | 106,415 |
Last Trade Date Time: | 07/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$20.58 | $20.61 | $20.58 | $20.77 | $20.43 | 106,415 | 07-25-2024 |
$20.5 | $20.46 | $20.5 | $20.61 | $20.385 | 72,446 | 07-24-2024 |
$20.49 | $20.55 | $20.49 | $20.59 | $20.45 | 74,416 | 07-23-2024 |
$20.5 | $20.54 | $20.5 | $20.575 | $20.44 | 66,717 | 07-22-2024 |
$20.4 | $20.49 | $20.4 | $20.49 | $20.32 | 54,657 | 07-19-2024 |
$20.49 | $20.5 | $20.49 | $20.63 | $20.35 | 80,536 | 07-18-2024 |
$20.42 | $20.37 | $20.42 | $20.4992 | $20.35 | 135,477 | 07-17-2024 |
$20.35 | $20.17 | $20.35 | $20.35 | $20.1445 | 98,415 | 07-16-2024 |
$20.13 | $20.23 | $20.13 | $20.23 | $20.05 | 232,240 | 07-15-2024 |
$20.24 | $20.66 | $20.24 | $20.7 | $20.12 | 500,181 | 07-12-2024 |
$20.51 | $20.54 | $20.51 | $20.68 | $20.43 | 148,953 | 07-11-2024 |
$20.382 | $20.2231 | $20.382 | $20.4068 | $20.2231 | 74,469 | 07-10-2024 |
$20.35 | $20.4 | $20.35 | $20.4799 | $20.29 | 89,654 | 07-09-2024 |
$20.34 | $20.39 | $20.34 | $20.58 | $20.27 | 100,835 | 07-08-2024 |
$20.35 | $20.6 | $20.35 | $20.63 | $20.3 | 60,204 | 07-05-2024 |
$20.48 | $20.3 | $20.48 | $20.55 | $20.29 | 77,232 | 07-04-2024 |
$20.48 | $20.3 | $20.48 | $20.55 | $20.29 | 77,232 | 07-03-2024 |
$20.22 | $20.05 | $20.22 | $20.28 | $20.03 | 101,661 | 07-02-2024 |
$20.08 | $20.32 | $20.08 | $20.38 | $20 | 103,915 | 07-01-2024 |
$20.21 | $20.24 | $20.21 | $20.3199 | $20.09 | 156,384 | 06-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest Company Name:
HTD Stock Symbol:
NYSE Market:
2024-07-12 04:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 05:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Results from the CATALYST clinical trial were presented at the American Diabetes Association’s 84 th Scientific Sessions at a featured plenary session titled: “Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes” With 1,055 patients enro...